Shigeo Kure MD, PhD

Shigeo Kure is a professor at, Department of Pediatrics, Tohoku University School of Medicine, Japan. He also serves as a deputy director of Tohoku Medical Megabank Organization (Tommo), which has established and follows the biggest genome cohort in Japan with 150,000 participants in Sendai city. He is a pediatric geneticist and has identified many disease-causing genes, including nonketotic hyperglycinemia, hereditary galactosemia type IV, steroid-dependent nephrotic syndrome, and Moyamoya disease.

In 1999, he proposed a new disease entity of tetrahydrobiopterin-responsive PKU, providing a therapeutic basis of the first drug therapy for PKU. For his research, he received the Grand Prize from the Japanese Society of Inherited Metabolic Disease in 2010, and the Commendation for Science and Technology from the Minister of Education, Culture, Sports, Science and Technology in 2014.